Eli Lilly Chief Financial Officer Lucas Montarce says their weight loss pill is on track to launch in the US in the second quarter, pending approval by the Food and Drug Administration. Montarce says they “feel good about the progress.” He speaks to Katie Greifeld.

Former SEC Chair Gary Gensler Talks SpaceX & Mega IPO Risks
09:04

Jim Chanos Talks SpaceX IPO
13:48

US Energy Secretary Chris Wright Talks Oil Flows Through Strait of Hormuz
26:52